Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Shield Thera (STX) Share Price

Price 8.15p on 04-09-2025 at 13:34:30
Change 1.85p 29.37%
Buy 8.30p
Sell 8.00p
Last Trade: Sell 100,000.00 at 8.13p
Day's Volume: 22,572,096
Last Close: 6.30p
Open: 6.60p
ISIN: GB00BYV81293
Day's Range 7.20p - 8.85p
52wk Range: 2.20p - 8.85p
Market Capitalisation: £84.90m
VWAP: 7.993832p
Shares in Issue: 1.04b

Shield Thera (STX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 100,000 8.13p Ordinary
14:34:30 - 04-Sep-25
Sell* 5,731 8.10p Ordinary
14:34:18 - 04-Sep-25
Buy* 114 8.30p SI Trade
14:29:01 - 04-Sep-25
Buy* 12 8.30p SI Trade
14:29:01 - 04-Sep-25
Sell* 100 8.00p SI Trade
14:29:01 - 04-Sep-25
Buy* 240 8.30p SI Trade
14:29:01 - 04-Sep-25
Sell* 908 8.00p SI Trade
14:29:01 - 04-Sep-25
Sell* 94 8.00p SI Trade
14:29:01 - 04-Sep-25
Buy* 100 8.30p SI Trade
14:29:01 - 04-Sep-25
Sell* 76,128 8.066p Ordinary
14:25:28 - 04-Sep-25
See more Shield Thera trades

Shield Thera (STX) Share Price History

Time period:
to
Date Open High Low Close Volume
3rd Sep 2025 (Wed) 6.95 6.85 6.30 6.30 6,236,857
2nd Sep 2025 (Tue) 6.95 6.95 6.95 6.95 2,069,265
1st Sep 2025 (Mon) 7.00 7.00 6.80 6.80 1,982,544
29th Aug 2025 (Fri) 7.75 7.75 6.90 7.00 9,698,994
28th Aug 2025 (Thu) 8.10 8.10 7.75 7.75 3,030,259
27th Aug 2025 (Wed) 7.70 8.30 7.70 8.10 5,256,290
26th Aug 2025 (Tue) 8.05 7.50 7.50 7.50 4,933,893
25th Aug 2025 (Mon) 8.06 8.06 8.06 8.06 0
22nd Aug 2025 (Fri) 7.15 8.30 7.50 8.06 11,970,059
21st Aug 2025 (Thu) 6.65 7.15 7.10 7.15 9,704,493
20th Aug 2025 (Wed) 7.05 6.70 6.55 6.70 4,787,719
19th Aug 2025 (Tue) 6.30 7.34 6.70 7.05 12,807,244
18th Aug 2025 (Mon) 5.65 6.50 6.05 6.50 5,994,874
15th Aug 2025 (Fri) 5.55 5.80 5.52 5.65 2,026,762
14th Aug 2025 (Thu) 5.15 5.70 5.15 5.55 9,475,387
13th Aug 2025 (Wed) 4.60 5.20 5.20 5.20 5,593,089
12th Aug 2025 (Tue) 4.60 4.60 4.60 4.60 748,624
11th Aug 2025 (Mon) 4.60 4.60 4.60 4.60 1,706,148
8th Aug 2025 (Fri) 4.60 4.60 4.60 4.60 1,022,650
7th Aug 2025 (Thu) 4.60 4.60 4.60 4.60 120,121
6th Aug 2025 (Wed) 4.60 4.60 4.60 4.60 385,580
5th Aug 2025 (Tue) 4.60 4.60 4.60 4.60 881,236
4th Aug 2025 (Mon) 4.60 4.50 4.50 4.50 138,511
See more Shield Thera price history

Shield Thera (STX) Regulatory News

Date Source Headline
3rd Sep 2025 2:17 pm RNS Interim results for the six months ended 30 Jun 25
27th Aug 2025 7:13 am RNS Data published -European Journal of Heart Failure
21st Aug 2025 12:06 pm RNS Interim results for the six months ended 30 Jun 25
23rd Jul 2025 7:00 am RNS Q2 2025 Trading Update
22nd May 2025 5:06 pm RNS Result of AGM
24th Apr 2025 7:06 am RNS Audited results for the year ended 31 Dec 2024
22nd Apr 2025 7:01 am RNS Licence Agreement in Japan for ACCRUFeR®
17th Apr 2025 11:23 am RNS Q1 2025 Trading Update
11th Mar 2025 7:00 am RNS ACCRUFeR® launched in Canada
13th Feb 2025 4:15 pm RNS PDMR Transaction Notification
See more Shield Thera regulatory news

Shield Thera (STX) Share News

LONDON MARKET MIDDAY: Europe mixed as UK construction optimism sinks

4th Sep 2025 12:02

(Alliance News) - London stocks remained mostly higher at midday on Thursday, as UK construction optimism sank to its lowest level in two and a half years. Read More

Shield Therapeutics climbs as Accrufer granted US FDA Priority Review

4th Sep 2025 11:51

(Alliance News) - Shield Therapeutics PLC on Thursday reported progress toward expanding the patient population for its oral treatment for those with iron deficiency with or without anaemia. Read More

Shield Therapeutics shares rise as US sales boost interim revenue

21st Aug 2025 12:58

(Alliance News) - Shield Therapeutics PLC on Thursday reported a narrowing of its half-year loss, bolstered by US sales and milestone payments globally, as it backed its full-year cash flow guidance. Read More

AIM WINNERS & LOSERS: CPPGroup rises as agrees sale of India business

23rd Jul 2025 11:01

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Wednesday. Read More

Shield Therapeutics revenue jumps on rising Accrufer prescriptions

23rd Jul 2025 09:55

(Alliance News) - Shield Therapeutics PLC on Wednesday said it is on track to turn free cash flow positive by the end of the year, as the pharmaceutical company reported a sharp rise in second quarter revenue. Read More

See more Shield Thera news
FTSE 100 Latest
Value9,221.85
Change43.86

Login to your account

Forgot Password?

Not Registered